Evotec SE (NASDAQ:EVO) Q3 2023 Earnings Call Transcript November 11, 2023
Werner Lanthaler: Welcome to our — good morning. Good afternoon. Welcome to our Q3 Call. Resilient into the Future of Biopharma R&D. That’s how we titled this presentation, which we have uploaded to the Internet and you are welcome to join this call also with the presentation. Resilience is all about being able to overcome the unexpected. Our goal of resilience is to follow science and technology and thrive together...
